Table 2 World Health Organization trial registration data set
Data category | Information |
|---|---|
Primary registry and trial identifying number | ClinicalTrials.gov, NCT03527667 |
Date of registration in primary registry | May 4, 2018 |
Secondary identifying numbers | N/A |
Source(s) of monetary or material support | Cancer Research UK PO Box 1561 Oxford OX4 9GZ Phone: 0300 123 1022 |
Primary sponsor | Cancer Research UK |
Secondary sponsor(s) | Stephenson Cancer Center |
Contact for public queries | Sydney Martinez, PhD (405)271-2229, sydney-martinez@ouhsc.edu |
Contact for scientific queries | Sydney Martinez, PhD (405)271-2229, sydney-martinez@ouhsc.edu |
Public title | Incentivized smoking cessation for diabetics |
Scientific title | Incentivized smoking cessation for tobacco treatment-resistant diabetics |
Countries of recruitment | United States, United Kingdom |
Health condition(s) or problem(s) studied | Diabetes, smoking |
Intervention(s) | 6-weeks vs 12-weeks of financial incentives for proof of abstinence |
Key inclusion and exclusion criteria | Inclusion criteria—ages 18 to 75, type 2 diabetes diagnosis greater than 1 year prior to enrollment, currently smoking at least 5 cigarettes per day, self-reported quit attempt in past 12 months Exclusion criteria—unwilling to make a quit attempt through usual care, unable to use smartphone and iCO™ Smokerlyzer® following training session |
Study type | Interventional (clinical trial) Allocation: randomized Exploratory |
Date of first enrolment | June 22, 2018 |
Target sample size | 60 |
Recruitment status | Recruiting |
Primary outcome(s) | Proportion of CO readings completed |
Key secondary outcomes | Quit outcomes; cigarettes per day |